ICIA 2023 - Important Update
This is to inform that ICIA 2023 event is now merged with
WCID 2023 which will be held on same dates October 23 25, 2023 in
Boston, Massachusetts, USA and virtually.
For complete details about the merged event, please visit:
https://infectious-diseases-conferences.magnusgroup.org/
For further details, please contact us at
infection@magnusconference.com or call + 1 (702) 988 2320
WCID 2023 which will be held on same dates October 23 25, 2023 in
Boston, Massachusetts, USA and virtually.
For complete details about the merged event, please visit:
https://infectious-diseases-conferences.magnusgroup.org/
For further details, please contact us at
infection@magnusconference.com or call + 1 (702) 988 2320
OK
HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.
International Conference on
Clinical Immunology and Allergy
October 19 -20, 2022 | Online Event
Event Book
Event program
Scientific Program
About
Magnus Group is pleased to announce the successful conclusion of the "International Conference on Clinical Immunology and Allergy," held as an Online Event on October 19-20, 2022. ICIA 2022 brought together a distinguished group of speakers who shared their expertise and engaged in discussions on cutting-edge topics within the realm of Clinical Immunology and Allergy. This renowned conference, organized by Magnus Group, attracted a diverse audience, including accomplished researchers, business delegates, and talented students from various countries worldwide. The event was marked by the participation of young and brilliant minds, contributing to the overall success of ICIA 2022.
Scientific Committee Members
Zhaohua Zhou
Food and Drug Administration, United States
Ranjan Ramasamy
IDFISH Technology, United States
Ismail Osmanov
Children's city clinical hospital, Russian FederationSpeakers
Matthias Hardtke Wolenski
Hannover Medical School, Germany
Alec Bigness
University of South Florida Morsani College of Medicine, United States
Laura Elisa Buitrago Molina
Hannover Medical School, Germany
Lissete Sanchez Magraner
Hawk Biosystems, SpainGallery
Pharma Conference 2019 | Paris, France
Pharma Conference 2018 | Rome, Italy
Pharmaceutics Conference 2017 | Valencia, Spain
Reviews
Pharma Conference 2018 | Rome, Italy
Pharma Conference 2017 | Valencia, Spain
Magnus Group Conferences Reveiws
Title : Diagnosis and differentiation of lyme disease and tick-borne relapsing fever borreliosis with multiplex line immunoblots
Ranjan Ramasamy, IDFISH Technology, United States
Title : Mast cell degranulation links anti-PEG IgE to anaphylaxis caused by PEGylated drugs and PEG-contained LNP/mRNA COVID vaccines
Zhaohua Zhou, Food and Drug Administration, United States
Title : Genetic factors influencing early immunity to SARS-CoV-2 in the upper respiratory tract
Ranjan Ramasamy, IDFISH Technology, United States
Title : Monoclonal antibodies efficacy in treatment of novel coronavirus infection (COVID-19) in children at risk of developing a severe course of the disease
Ismail Osmanov, Children's city clinical hospital, Russian Federation
Title : Considerations on MS animal modeling: Format of myelin immunogens used for experimental autoimmune encephalomyelitis model establishment may affect pharmacologic responses of anti-inflammatory drugs
WenQing Yang, Founder/Chief Scientific Officer, ClinBridge Biotech Corp., China
Title : Regulatory T cells with chimeric antigen receptors as treatment for autoimmunity
Matthias Hardtke Wolenski, Hannover Medical School, Germany